Discontinued — last reported Q3 '25
Other
Redeemable noncontrolling interests in subsidiaries
Thermo Fisher Scientific Redeemable noncontrolling interests in subsidiaries decreased by 0.8% to $121.00M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ3 2021
Last reportedQ3 2025
How to read this metric
An increase indicates a higher potential future cash outflow obligation to minority shareholders, which may impact liquidity.
Detailed definition
This represents the portion of equity in a subsidiary that is attributable to noncontrolling interests, which is subject...
Peer comparison
Found in companies with complex organizational structures or joint venture arrangements; peers with significant M&A activity often carry these balances.
Metric ID:
other_redeemable_noncontrolling_interest_equity_carrying_amountHistorical Data
4 periods
| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $120.00M | $128.00M | $122.00M | $121.00M |
| QoQ Change | — | +6.7% | -4.7% | -0.8% |
| YoY Change | — | — | +1.7% | -5.5% |
Range$120.00M – $128.00M
Avg YoY Growth-1.9%
Median YoY Growth-1.9%
Current Streak2 quarters decline
Redeemable noncontrolling interests in subsidiaries at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's redeemable noncontrolling interests in subsidiaries?
- Thermo Fisher Scientific (TMO) reported redeemable noncontrolling interests in subsidiaries of $121.00M in Q1 2026.
- What does redeemable noncontrolling interests in subsidiaries mean?
- The value of minority-owned stakes in subsidiaries that the company may be required to buy back under certain conditions.